Transurethral resection of bladder tumor (TURBT) accounts for much of the pathologic response in patients with muscle-invasive bladder cancer (MIBC) receiving neoadjuvant chemotherapy (NAC) and TURBT prior to radical cystectomy, according to findings presented Friday at the 2016 Genitourinary Cancers Symposium in San Francisco.